VRDN 19.52 ▲ 2.31% Live Trading Data - Stocknear

Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
19.52
0.44 (2.31%)
At close: Sep 26, 2025, 11:05 AM
2.31%
Bid 13.92
Market Cap 1.59B
Revenue (ttm) 305K
Net Income (ttm) -344.06M
EPS (ttm) -3.57
PE Ratio (ttm) -5.47
Forward PE -4.83
Analyst Buy
Dividends n/a
Ask 24.75
Volume 50,266
Avg. Volume (20D) 773,847
Open 19.16
Previous Close 19.08
Day's Range 18.92 - 19.61
52-Week Range 9.90 - 27.20
Beta 0.58
Ex-Dividend Date n/a

About VRDN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRDN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VRDN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Viridian Therapeutics Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+6.02%
Viridian Therapeutics shares are trading higher af... Unlock content with Pro Subscription
4 months ago
+7.8%
Viridian Therapeutics shares are trading higher after the company announced positive long-term durability data from its THRIVE Phase 3 clinical trial of veligrotug in TED patients.